Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1990 1
1992 2
1994 1
1996 2
1997 1
1998 2
1999 1
2000 1
2001 5
2002 4
2003 2
2004 4
2005 8
2006 8
2007 3
2008 3
2009 7
2010 4
2011 1
2012 3
2013 4
2014 5
2015 7
2016 4
2017 5
2018 6
2019 3
2020 1
2021 2
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 15709124

96 results
Results by year
Filters applied: . Clear all
Page 1
Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972.
van den Bent MJ, Chinot O, Boogerd W, Bravo Marques J, Taphoorn MJ, Kros JM, van der Rijt CC, Vecht CJ, De Beule N, Baron B. van den Bent MJ, et al. Ann Oncol. 2003 Apr;14(4):599-602. doi: 10.1093/annonc/mdg157. Ann Oncol. 2003. PMID: 12649108 Free article. Clinical Trial.
Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities.
Buckner JC, Gesme D Jr, O'Fallon JR, Hammack JE, Stafford S, Brown PD, Hawkins R, Scheithauer BW, Erickson BJ, Levitt R, Shaw EG, Jenkins R. Buckner JC, et al. J Clin Oncol. 2003 Jan 15;21(2):251-5. doi: 10.1200/JCO.2003.06.023. J Clin Oncol. 2003. PMID: 12525516 Clinical Trial.
96 results